Dattananda Chelur

Title: Dattananda Chelur: Innovator in Binding Molecules

Introduction

Dattananda Chelur is a notable inventor based in Chesterbrook, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of binding molecules that target specific proteins involved in various diseases. With a total of four patents to his name, Chelur's work has the potential to impact therapeutic strategies significantly.

Latest Patents

Chelur's latest patents include innovative discoveries related to CD19 and CD2 binding molecules. The first patent focuses on CD19 binding molecules that specifically bind to CD19, including monospecific, bispecific, and trispecific binding molecules. This patent also covers conjugates and pharmaceutical compositions that utilize these binding molecules. Furthermore, it outlines methods for using CD19 binding molecules to treat diseases associated with CD19 expression. The second patent involves CD2 binding molecules that specifically bind to CD2, which also includes various binding formats. This patent emphasizes the modulation of CD2 signaling to treat autoimmune, inflammatory, and proliferative disorders. It also details the engineering of recombinant host cells to express these binding molecules.

Career Highlights

Throughout his career, Dattananda Chelur has worked with prominent companies in the biotechnology sector, including Lifesensors, Inc. and Novartis AG. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Chelur has collaborated with notable professionals in his field, including Michael Eddins and Craig Leach. These collaborations have likely enhanced his research and development efforts, leading to impactful innovations.

Conclusion

Dattananda Chelur is a distinguished inventor whose work in binding molecules has the potential to revolutionize treatment options for various diseases. His contributions to biotechnology reflect a commitment to advancing medical science through innovation.